OBJECTIVE: Inflammatory activity in fat tissue has recently been implicated in mechanisms of insulin resistance and obesity-related metabolic dysfunction. Toll-like receptors (TLRs) play a key role in innate immune responses and recent studies implicate the TLR pathway in mechanisms of inflammation and atherosclerosis. The aim of this study was to examine differential TLR expression and function in human adipose tissue. METHODS AND PROCEDURES: We biopsied subcutaneous abdominal fat from 16 obese subjects (age 39+/-11 years, BMI 49+/-14 kg/m2) and characterized TLR expression using quantitative real-time PCR and confocal immunofluorescence imaging. In tissue culture, we stimulated isolated human adipocytes with Pam3CSK4 and lipopolysaccharide (LPS) (TLR2 and TLR4 agonists, respectively) and quantified TLR activity, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) production, and nuclear factor-kappaB (NF-kappaB) p65 nuclear activation using real-time PCR, enzyme-linked immunosorbent assay (ELISA), and immunofluorescence. RESULTS: TLR1, 2, and 4 protein colocalized with adiponectin in human adipocytes with TLR4 exhibiting the highest immunohistochemical expression. Using real-time PCR, we confirmed higher level of gene expression for TLR4 as compared to other members of the TLR family (TLR1, 2, 7, 8) in human adipose depots (P<0.001). In tissue culture, adipocyte TLR2/TLR4 mRNA expression and protein increased significantly following Pam3CSK4 and LPS (P<0.001). TLR2/TLR4 stimulation was associated with NF-kappaB p65 nuclear translocation and proinflammatory cytokine production. DISCUSSION: The findings demonstrate that TLRs are inducible in adipose tissue and linked with downstream NF-kappaB activation and cytokine release. Adipose stores may play a dynamic role in the regulation of inflammation and innate immunity in human subjects via modulation of the TLR/NF-kappaB regulatory pathway.
OBJECTIVE: Inflammatory activity in fat tissue has recently been implicated in mechanisms of insulin resistance and obesity-related metabolic dysfunction. Toll-like receptors (TLRs) play a key role in innate immune responses and recent studies implicate the TLR pathway in mechanisms of inflammation and atherosclerosis. The aim of this study was to examine differential TLR expression and function in human adipose tissue. METHODS AND PROCEDURES: We biopsied subcutaneous abdominal fat from 16 obese subjects (age 39+/-11 years, BMI 49+/-14 kg/m2) and characterized TLR expression using quantitative real-time PCR and confocal immunofluorescence imaging. In tissue culture, we stimulated isolated human adipocytes with Pam3CSK4 and lipopolysaccharide (LPS) (TLR2 and TLR4 agonists, respectively) and quantified TLR activity, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) production, and nuclear factor-kappaB (NF-kappaB) p65 nuclear activation using real-time PCR, enzyme-linked immunosorbent assay (ELISA), and immunofluorescence. RESULTS: TLR1, 2, and 4 protein colocalized with adiponectin in human adipocytes with TLR4 exhibiting the highest immunohistochemical expression. Using real-time PCR, we confirmed higher level of gene expression for TLR4 as compared to other members of the TLR family (TLR1, 2, 7, 8) in human adipose depots (P<0.001). In tissue culture, adipocyte TLR2/TLR4 mRNA expression and protein increased significantly following Pam3CSK4 and LPS (P<0.001). TLR2/TLR4 stimulation was associated with NF-kappaBp65 nuclear translocation and proinflammatory cytokine production. DISCUSSION: The findings demonstrate that TLRs are inducible in adipose tissue and linked with downstream NF-kappaB activation and cytokine release. Adipose stores may play a dynamic role in the regulation of inflammation and innate immunity in human subjects via modulation of the TLR/NF-kappaB regulatory pathway.
Authors: Samuel Klein; Lora E Burke; George A Bray; Steven Blair; David B Allison; Xavier Pi-Sunyer; Yuling Hong; Robert H Eckel Journal: Circulation Date: 2004-10-27 Impact factor: 29.690
Authors: Tamara Tchkonia; Yourka D Tchoukalova; Nino Giorgadze; Tamar Pirtskhalava; Iordanes Karagiannides; R Armour Forse; Ada Koo; Michael Stevenson; Dharmaraj Chinnappan; Andrew Cartwright; Michael D Jensen; James L Kirkland Journal: Am J Physiol Endocrinol Metab Date: 2004-09-21 Impact factor: 4.310
Authors: Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi Journal: Proc Natl Acad Sci U S A Date: 2004-07-12 Impact factor: 11.205
Authors: Gunnar Engström; Bo Hedblad; Lars Stavenow; Susanna Jonsson; Peter Lind; Lars Janzon; Folke Lindgärde Journal: Arterioscler Thromb Vasc Biol Date: 2004-06-03 Impact factor: 8.311
Authors: Kristina Edfeldt; Anna M Bennet; Per Eriksson; Johan Frostegård; Björn Wiman; Anders Hamsten; Göran K Hansson; Ulf de Faire; Zhong-qun Yan Journal: Eur Heart J Date: 2004-08 Impact factor: 29.983
Authors: Harry Björkbacka; Vidya V Kunjathoor; Kathryn J Moore; Stephanie Koehn; Christine M Ordija; Melinda A Lee; Terry Means; Kristen Halmen; Andrew D Luster; Douglas T Golenbock; Mason W Freeman Journal: Nat Med Date: 2004-03-14 Impact factor: 53.440
Authors: Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland Journal: Cell Metab Date: 2013-04-11 Impact factor: 27.287
Authors: Tamara Tchkonia; Dean E Morbeck; Thomas Von Zglinicki; Jan Van Deursen; Joseph Lustgarten; Heidi Scrable; Sundeep Khosla; Michael D Jensen; James L Kirkland Journal: Aging Cell Date: 2010-08-15 Impact factor: 9.304
Authors: Rachana Shah; Yun Lu; Christine C Hinkle; Fiona C McGillicuddy; Roy Kim; Sridhar Hannenhalli; Thomas P Cappola; Sean Heffron; XingMei Wang; Nehal N Mehta; Mary Putt; Muredach P Reilly Journal: Diabetes Date: 2009-07-06 Impact factor: 9.461